martes, 14 de mayo de 2019

Grail, the liquid biopsy startup, picks an approach for its cancer test - STAT

Grail, the liquid biopsy startup, picks an approach for its cancer test - STAT

Cancer Briefing

Grail, the liquid biopsy startup, picks an approach for its cancer test

By MATTHEW HERPER


ADOBE
The San Francisco-based company previously presented data on three different approaches to detect cancer using DNA circulating in the blood.

No hay comentarios: